420 with CNW — Oklahoma Grapples with Inconsistent Marijuana Testing Standards, Lab Shopping

Oklahoma’s medical cannabis industry is facing renewed scrutiny as concerns over varying laboratory findings fuel debate about product safety and the effectiveness of current oversight.

For Oklahoma patient Summer Parker, those concerns became deeply personal. She recalled experiencing severe episodes after smoking pre-rolls from Graves Farm Organics. According to Parker, she struggled to think clearly, had difficulty speaking, collapsed, and eventually required emergency medical assistance.

At first, she did not suspect the cannabis product. However, after similar incidents repeatedly followed the use of the same brand, she and her spouse, Charles Hrabina, decided to have several products independently analyzed.

Their lawsuit against the business alleges that testing revealed multiple pesticide failures, one microbial contamination issue, and a lower THC level than the manufacturer advertised.

The company and its founder, Michael Graves, deny any connection between the products and Parker’s medical episodes. Attorney Felina Rivera, representing the company, rejected claims that the products were defective but argued that Oklahoma’s marijuana testing framework suffers from major inconsistencies.

Rivera said identical samples submitted to several licensed laboratories can produce very different outcomes, a criticism echoed by others throughout the cannabis industry. The disagreement has intensified questions about whether patients can rely on the certificates of analysis that accompany legal marijuana products.

State law requires every medical cannabis product sold in Oklahoma to undergo testing before reaching dispensaries. Licensed laboratories examine samples for contaminants, including pesticides, heavy metals, microbes, mycotoxins, and residual solvents, while also measuring cannabinoid potency and terpene content.

Each approved batch receives a certificate of analysis documenting test results and confirming whether it met state requirements. Products that fail safety requirements cannot legally enter the marketplace.

Laboratories must be accredited, participate in proficiency testing, and follow standards established by the Oklahoma Medical Marijuana Authority (OMMA). They are also required to maintain safeguards intended to prevent financial interests from influencing laboratory findings.

Critics say that even with those protections, the pressure to compete makes producers want to find labs that are more likely to give them better results. Since THC percentages strongly influence purchasing decisions, even modest differences in reported potency can affect both pricing and sales.

OMMA acknowledges that lab shopping exists nationwide and says stronger oversight is essential. Since Oklahoma’s medical cannabis program launched, regulators have taken enforcement action against 29 laboratories. Some facilities have also been required to correct deficiencies after failing proficiency evaluations.

A 2023 law authorized OMMA to establish its own quality assurance laboratory to verify testing accuracy. Although the facility is still completing accreditation for several testing categories, officials say it already performs limited analyses for potency and pesticides. Once fully operational, it will compare identical samples across laboratories, conduct independent testing during investigations, and monitor overall laboratory performance.

Parker has since become an advocate for stronger oversight, co-founding Patients for Safe Access of Oklahoma. She said independent testing of roughly 40 products over two years revealed concerns extending beyond a single producer, including compounds not covered by Oklahoma’s required screening panel.

Outside Oklahoma’s regulated medical cannabis market, concerns grow even larger. Hemp-derived products containing intoxicating THC variants are sold through retailers that are not subject to the same testing standards, inspections, or consumer protections, leaving many experts warning that buyers face even greater uncertainty.

The entire marijuana industry, including established companies like SNDL Inc. (NASDAQ: SNDL), would want the issues linked to product testing addressed in different legal markets so that legally sourced products don’t trigger any doubts in the minds of consumers who should naturally trust the product labels attached to these items.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Virginia Authorities Seek Public Views on Planned Marijuana Program

As Virginia moves toward the start of a regulated retail cannabis industry, the state Cannabis Control Authority is asking residents and businesses to share their views through a new public survey.

The questionnaire became available on July 6 and is designed to gather opinions on future rules governing the state’s marijuana market. Officials say they want to hear from individuals, organizations, and communities that either participate in or are affected by the changing cannabis landscape.

Jamie Patten of the CCA said the outreach effort is intended to ensure that people with firsthand experience and those who may feel the effects of new policies have an opportunity to contribute to the discussion. According to Patten, input from stakeholders plays an important role as the agency develops regulations focused on public safety, health protections, and the creation of an orderly and accountable marketplace.

Virginia’s retail cannabis framework was established through the state budget approved earlier this year. The budget measures were accompanied by several cannabis-related bills that passed the legislature and received the signature of Governor Abigail Spanberger.

The survey will remain open until July 21. Agency leaders said responses collected during that period will help them better understand the range of viewpoints surrounding the emerging industry. Information gathered through the survey is expected to guide planning efforts and support decision-making as regulators continue shaping the state’s cannabis policies. Officials noted that all submissions will be reviewed during the rulemaking process.

Another significant development involves changes to hemp oversight in Virginia. Responsibilities currently handled by the Office of Hemp Enforcement are being transferred to the CCA. Those duties are presently administered by the Virginia Department of Agriculture and Consumer Services (VDACS), but the transition is expected to take effect in August 2026.

State officials noted that registered hemp retailers and industrial hemp producers will receive direct updates from the agriculture department explaining how the upcoming administrative and legislative changes may affect their operations. The communications are expected to provide guidance on compliance requirements and other adjustments connected to the transition.

New legislation also changes how hemp products containing THC are regulated. Lawmakers have removed the previous “25:1 ratio” provision. Under that standard, certain hemp products could contain more than 2mg of THC as long as they included 25 parts cannabidiol (CBD) for every one-part THC.

Starting August 15, products containing more than 2mg of THC in a package will no longer qualify as hemp products that can be manufactured or sold in Virginia. As Virginia moves towards a regulated adult-use marijuana system, industry players like SNDL Inc. (NASDAQ: SNDL) will be watching how the actual implementation of the market plays out.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Missouri to Start Receiving Cannabis Microbusiness Applications in July

Missouri’s applications for 77 available cannabis licenses will be accepted from July 13 through July 27, with a random drawing set for September 9. Officials expect successful applicants to receive their licenses in December.

According to the Missouri Division of Cannabis Regulation, the microbusiness initiative was created to expand access to the legal cannabis market for individuals and groups that have historically faced barriers to participation. The program was established after voters approved recreational marijuana legalization through a constitutional amendment in 2022.

As preparations begin for the upcoming application period, the division’s chief equity officer, Lesley Turek, has spent recent weeks traveling across Missouri to explain the process and answer questions from prospective applicants.

A major focus of Turek’s presentations has been a series of regulatory changes that took effect in late May. State officials proposed the revisions last year after multiple licenses were revoked because of ownership arrangements that regulators determined violated constitutional requirements.

Under the updated framework, regulators can conduct thorough reviews before licenses are awarded rather than after recipients have already been selected. The rules also provide additional clarification regarding the constitutional requirement that qualified applicants must maintain majority ownership and operational control of their businesses.

The regulations further require direct communication between state officials and majority owners. In addition, applicants must complete compliance training before submitting an application and again after obtaining a license.

Missouri residents may qualify for the program through one of seven eligibility categories. These include income-based qualifications, previous cannabis-related arrests or incarceration, residence in economically disadvantaged communities, among other criteria.

Applicants must pay a $1,500 fee when submitting materials. Those who are not chosen in the lottery will receive a refund. The Missouri Lottery will randomly select recipients for dispensary and cultivation licenses, helping the state reach the constitutionally mandated minimum of 144 microbusiness licenses.

Turek said the application itself is designed to be accessible and far less complicated than the process required for larger cannabis business licenses. The division offers instructional resources, including tutorials and detailed guides, to help applicants complete the paperwork independently.

At the same time, she cautioned that operating a cannabis business involves significant costs and strict regulatory obligations. State officials want applicants to understand those realities before committing to the program.

Another key topic involves ensuring that eligible individuals truly control the businesses connected to the licenses. Regulators say ownership is not measured solely by percentage stakes but also by decision-making authority.

The state has also revised requirements surrounding designated contacts, who serve as the primary link between license holders and regulators. Officials found cases in which designated representatives failed to keep eligible owners fully informed, resulting in agreements that reduced their influence and financial benefits.

To address those concerns, Missouri now requires pre-application training that includes online instruction about recognizing and avoiding potentially predatory business practices.

This streamlined approach to increasing the number of microbusinesses participating in the legal marijuana market in Missouri is welcome news to marijuana companies within and outside the U.S., such as SNDL Inc. (NASDAQ: SNDL).

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Documents Marijuana’s Protective Effects Against Diabetes

New research from the University of California, Riverside, has shed light on a long-standing question surrounding cannabis use and metabolic health. While marijuana is widely known for stimulating appetite, regular users have frequently been found to have lower body weight and a reduced likelihood of developing type 2 diabetes compared with non-users.

For years, population-based studies have suggested that people who use cannabis regularly often display more favorable metabolic indicators than those who do not. This observation has puzzled scientists because cannabis is commonly associated with increased food consumption, often referred to as the “munchies.”

The new study examined whether substances naturally present in cannabis, apart from delta-9 tetrahydrocannabinol (THC), could help explain the phenomenon.

To investigate, scientists used obese mice fed diets intended to resemble typical human eating habits. The animals received either purified THC or a whole-plant cannabis extract. Importantly, both treatments contained identical amounts of THC, allowing the team to determine whether additional cannabis compounds influenced metabolic outcomes.

The results showed that both groups of mice experienced substantial weight reduction. However, differences emerged when researchers assessed blood sugar regulation. Animals treated solely with THC continued to exhibit problems linked to glucose control, a hallmark of type 2 diabetes. In contrast, mice given the full cannabis extract not only lost weight but also demonstrated significant improvement in metabolic function.

According to the study’s authors, the findings indicate that THC by itself does not account for the positive metabolic effects observed in some cannabis users. Instead, other components of the plant appear to contribute significantly.

Further analysis suggested that communication between fat tissue and the pancreas may play a central role. Under healthy conditions, fat cells release signaling molecules that help regulate insulin production. In obesity and diabetes, this process can become impaired, contributing to elevated blood sugar levels.

Researchers found that the whole-plant extract was more effective than THC alone at restoring this biological signaling pathway. Improved communication between fat tissue and the pancreas appeared to support healthier glucose regulation.

Despite the promising findings, the authors stressed that the research should not be interpreted as evidence that cannabis can treat obesity or diabetes. They also stressed the need for human trials before any medical conclusions can be reached.

The team now plans to identify non-intoxicating cannabis compounds that may offer metabolic benefits without producing THC’s psychoactive effects. As cannabis use expands and regulations continue to change, researchers say ongoing scientific investigation will be essential to better understand both its potential advantages and its risks.

Marijuana firms like SNDL Inc. (NASDAQ: SNDL) are unlikely to be surprised that recent studies are starting to document the various beneficial health effects of marijuana. Such scientific findings contradict what critics and prohibitionists have always claimed against marijuana.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Spanberger Vetoes Virginia Bills Establishing Marijuana Sales System

Virginia Gov. Abigail Spanberger has vetoed two measures aimed at launching a legal retail cannabis industry, arguing that the proposals arrived too soon and lacked safeguards needed for a responsible rollout. In her veto message, the governor said Virginia was not yet fully equipped to introduce a commercial system without creating risks tied to regulation, enforcement, and public safety.

Spanberger said any future system should place emphasis on public safety, youth protection, product quality, and accountability. She also pointed to lessons from other states, arguing that Virginia must be fully prepared with adequate testing, inspections, and enforcement tools before retail sales begin. The governor added that she remains open to continued discussions with legislators, law enforcement agencies, and other interested groups.

Despite legalizing recreational cannabis in 2021, lawmakers intentionally delayed the creation of commercial sales, separating legalization of possession from a retail framework. As a result, adults in Virginia may legally possess up to one ounce of cannabis and cultivate as many as four plants for personal use, but no legal marketplace currently exists for purchasing the product.

The effort to authorize sales has faced repeated setbacks. Former Gov. Glenn Youngkin blocked similar legislation in 2024 and 2025, preventing lawmakers from moving ahead with a regulated system.

During her campaign, Spanberger signaled support for eventually creating a regulated cannabis market and promised to work with legislators on a workable approach. HB 642 and SB 542, companion proposals introduced during the session, aimed to establish licensed dispensaries and begin legal marijuana sales by January next year.

Earlier this year, Spanberger proposed several revisions to the legislation. Her recommendations included delaying implementation until July 2027, lowering the maximum number of dispensary licenses, and strengthening compliance and enforcement measures. The General Assembly declined to adopt those revisions, instead sending the bills back to the governor in their original form.

The veto likely delays legal marijuana sales in Virginia until at least 2028, depending on action taken during the next legislative session.

Virginia’s debate comes as cannabis policy shifts nationwide. Last month, federal authorities moved several cannabis-related substances to Schedule III under the Controlled Substances Act, easing some restrictions tied to medical use.

The move followed an executive order from President Donald Trump directing faster action on reclassification efforts. Separately, the Supreme Court recently declined to hear a challenge from Massachusetts cannabis businesses contesting federal marijuana laws.

The wider cannabis industry, including established firms like SNDL Inc. (NASDAQ: SNDL), will be disappointed that yet another effort to start legal marijuana sales in Virginia has hit a wall and residents who can’t grow their own marijuana will have to wait for much longer before they access products at licensed retail points.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Looming Federal Ban Causes Colorado Bill Regulating Hemp THC to Fail

Efforts to expand where hemp-derived THC beverages can be sold in Colorado stalled this week as lawmakers were unable to gather enough support to move the proposal forward.

SB 164 sought to open the door for these drinks to be offered in restaurants and bars, rather than limiting sales to licensed marijuana dispensaries. However, the measure was withdrawn by its lead sponsor after it became clear that it would not secure the votes needed to pass.

Opposition from segments of the state’s cannabis industry played a significant role in the outcome, according to reporting by The Denver Gazette.

Backers of the bill argued that the legislation could help the state develop a structured and regulated market for marijuana-infused beverages, a category that has been gaining traction with consumers. Under current rules, hemp-based drinks containing up to 1.75 mg of THC can be sold in venues such as liquor stores and bars. The proposed measure aimed to raise that cap to 10 mg of THC in a standard 12-ounce serving.

It also included provisions that would have allowed convenience and grocery stores to carry products with THC levels capped at 3 mg. Advocates said such changes could make the products more accessible while still maintaining safety standards.

Interest in marijuana beverages has been growing, particularly among consumers seeking alternatives to vaping or smoking. Industry observers note that some beverage companies are exploring THC-infused options as alcohol consumption trends shift and more people look for products aligned with health-conscious lifestyles.

Still, the debate highlighted an ongoing divide within Colorado’s broader cannabis sector. Some licensed marijuana businesses have expressed concern about competition from hemp-derived products, which are regulated differently.

During testimony before legislators, Adam Foster of the Responsible Cannabis Coalition criticized the proposal, describing it as an attempt by out-of-state hemp companies to enter Colorado’s market without adhering to the same regulatory framework required of cannabis operators. He urged legislators to maintain consistent oversight for all intoxicating THC products under state law.

At the federal level, uncertainty is also growing. Many hemp-derived THC products are expected to lose legal protections later this year, and attempts to delay or prevent that change have so far been unsuccessful.

Recent draft language for the Farm Bill approved by the House did not include provisions safeguarding these products, raising concerns for businesses that rely on them. Lawmakers in Washington have introduced various amendments in response to the looming restrictions. Representative Andy Barr proposed creating a regulatory system for such products but later withdrew his amendment. Another effort by Representative James Comer to extend the deadline by one year did not advance.

The Senate is expected to develop its own version of the Farm Bill in the coming months. A bipartisan proposal that would allow states to decide whether to permit hemp-derived THC products has yet to be considered in committee, leaving the future of the industry uncertain for now.

Licensed cannabis firms like SNDL Inc. (NASDAQ: SNDL) will be watching how U.S. federal lawmakers resolve the hemp THC issue and how any resultant regulatory changes reshape the intoxicating beverages landscape.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Nebraska Medical Marijuana Regulations Now Await AG and Governor’s Approval

The Nebraska Medical Cannabis Commission has approved a set of rules governing the state’s emerging cannabis supply system, almost a year after first adopting temporary guidelines.

The framework has operated under short-term extensions lasting 90 days at a time. The measures, repeatedly renewed, outline how medical marijuana businesses must operate. They address licensing limits, security standards, approved product types, and the qualifications required for physicians who recommend cannabis to patients.

The newly adopted rules now move to State Attorney General Mike Hilgers, who must review them for constitutional and legal compliance. Final approval rests with Governor Jim Pillen.

Both officials have previously raised concerns about the voter-backed measures that legalized medical cannabis and established regulatory oversight. When the laws took effect in December 2024 following strong voter support, Pillen and Hilgers questioned whether they aligned with federal law and the state constitution.

Marijuana remains classified by the federal government as a Schedule I drug, a category reserved for drugs considered to have high abuse potential and no accepted medical use.

This classification places Nebraska in an unusual position as it lacks federal protections that shield most other states with medical marijuana programs from interference. Currently, nearly every other state has some level of protection, though Nebraska was excluded from the most recent federal update earlier this year.

Despite earlier criticism, Pillen has taken steps to support the program’s administrative rollout. He approved temporary rules ahead of a July deadline set by voters and allocated over $2 million in the state budget to support operations within the Liquor Control Commission, which also oversees the cannabis program. The governor has framed medical cannabis access as a way to reduce reliance on recreational use.

Still, uncertainty remains. Advocates voiced concern during the recent commission meeting that the program may struggle to function following the collapse of a legislative proposal that would have protected physicians who recommend cannabis.

Patients can legally possess up to five ounces of marijuana with a recommendation from a licensed provider, even if that provider is based outside Nebraska. However, the commission has limited access to state-licensed dispensaries for patients with recommendations from in-state practitioners. So far, no Nebraska-based doctors have issued such recommendations, creating a major barrier for patients.

Some individuals have sought alternatives by traveling out of state, either to obtain recommendations or to purchase cannabis. Industry representatives warn that without local physician participation, access to regulated dispensaries could remain out of reach. The commission has indicated it may consider exceptions in the future, but currently maintains its preference for in-state oversight.

Meanwhile, the commission is moving forward with building its internal structure. Members voted to hire independent legal counsel rather than rely on the attorney general’s office, citing concerns about public perception. Plans are also underway to recruit an executive director and operational staff.

Delays in the final approval of the regulations could slow the rollout of licenses for dispensaries, manufacturers, and transporters, potentially disrupting supply later this year. For patients, who live with serious health conditions, the wait is increasingly difficult.

The commission is scheduled to meet again on May 11. Marijuana companies from far and wide, including SNDL Inc. (NASDAQ: SNDL), will be hoping that the governor signs off on these rules and the medical marijuana program stabilizes.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Finds That Marijuana Legalization Lowers Crime Rates

A new study suggests that marijuana legalization may be linked to changes in crime patterns over time. Researchers found that allowing cannabis for recreational use among adults appears connected to gradual declines in violent offenses, while laws permitting medical marijuana are associated with decreases in property-related crimes.

The study, published in Economic Modelling, explored how separate forms of legalization might affect criminal activity over time as more U.S. states adopt some version of cannabis reform.

According to the authors, the findings highlight a clear contrast between recreational and medical frameworks. Their statistical models suggest that each approach to regulated cannabis access corresponds with distinct patterns in crime rates.

The researchers noted that policy changes often have ripple effects that extend beyond their immediate goals. When a government alters the legal status of one activity, it can reshape incentives tied to other types of behavior. Marijuana reform provides a useful example because medical and recreational laws have been introduced at different times across the United States, offering a wide dataset for comparison.

Initial analysis suggested that allowing recreational use might lead to an increase in property offenses. However, after adjusting the models to account for long-term trends specific to each state, the apparent increase disappeared. Under those revised conditions, the relationship turned negative and no longer carried statistical significance.

Overall, the study emphasizes that results vary depending on how the data is analyzed. The authors said their findings do not support claims that legalization triggers a measurable surge in property crime. Instead, the research underscores the importance of careful methodology when assessing policy outcomes.

The study also found that any impact on crime develops slowly. Changes tend to appear several years after legalization rather than immediately. Because of this delay, the researchers cautioned advocates and policymakers against making quick claims about the benefits or costs of cannabis reform.

The study’s broader assessment proposes that medical cannabis laws correlate with declines in property crime, while recreational legalization aligns with reductions in violent incidents. The authors connect these results to the Becker hypothesis, a theory suggesting that when markets move from illegal to regulated systems, certain criminal activities may lose their economic incentives.

Exactly why recreational and medical cannabis legalization policies appear to influence crime differently remains unclear. Still, earlier studies have explored related questions.

One analysis of Atlanta’s decision to decriminalize cannabis found that violent crime dropped after police shifted attention toward more serious offenses. Research released in 2024 also reported a notable decline in intimate partner violence following recreational legalization.

Additional studies have examined national data and cross-state comparisons, with several suggesting cannabis reforms have little effect on crime overall, though some report reductions in specific categories such as burglary.

Marijuana firms, such as SNDL Inc. (NASDAQ: SNDL), may prefer that additional data is first obtained regarding the impacts of drug policy reform so that the mixed signals in the existing research are resolved.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Georgia Considers Bill to End Cannabis Odor as Basis for Police Searches

A proposal now before the Georgia legislature could significantly change how law enforcement officers handle traffic stops and searches, focusing on the long-debated practice of using the odor of cannabis as grounds for action.

House Bill 496, authored by Representative Jasmine Clark, would prevent officers from relying solely on cannabis scent to justify stopping or searching someone. The measure aims to revise the state’s criminal procedure rules to make clear that the scent of hemp or cannabis, whether smoked or not, does not by itself amount to reasonable suspicion or probable cause.

If enacted, the legislation would prohibit officers from detaining pedestrians, conducting traffic stops, or searching vehicles and occupants based only on what they claim to smell.

Clark defended the proposal during a recent hearing before the House Judiciary Non-Civil Committee. She told lawmakers that the presence of an odor, on its own, does not prove that a crime is taking place.

According to Clark, the bill is not intended to restrict proper police work. Instead, she said, it clarifies that actions taken by officers should be grounded in clear and verifiable factors. Hemp is legal under state law, while cannabis remains prohibited outside of limited medical use. That overlap, she said, creates room for confusion and legal challenges.

Civil liberties advocates have long criticized what is often referred to as the “smell test.” Organizations such as NORML argue that scent-based judgments are subjective and difficult to verify in court. Advocates of HB 496 argue that allowing searches solely based on an officer’s nose grants excessive discretion and may lead to unequal enforcement, especially in minority communities.

The proposal has met resistance from some GOP lawmakers and police departments. Senator Brian Strickland, who leads the Senate Judiciary Committee, voiced concerns about limiting investigative tools available to police. He said restricting officers from using their senses could make it harder to identify impaired drivers or individuals violating drug laws.

Strickland added that navigating the legal differences between cannabis and hemp may be complicated, but officers need broad authority to protect the public. Critics also argue that traffic stops prompted by suspected cannabis odor sometimes uncover more serious offenses, including illegal firearms and narcotics such as fentanyl and cocaine.

Robin Krockum, Habersham County Sheriff, said his department would adhere to any statutory changes approved by lawmakers. For now, HB 496 remains under review in committee as debate continues during the current legislative session.

Entities like SNDL Inc. (NASDAQ: SNDL) in the cannabis ecosystem will be following these debates and other regulatory developments not just in Georgia but also around the region to see how they could reshape the industry.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Massachusetts Considers Freezing Issuance of Marijuana Cultivation Licenses

Cannabis stores across Massachusetts are moving more product than in previous years as the number of licensed businesses reaches a record high in what has become a $1.6 billion annual industry. Even so, regulators are weighing a temporary halt on new cultivation licenses as growers grapple with falling wholesale and retail prices.

Massachusetts, like several other states, is facing a glut of product. That imbalance has driven prices down sharply. Data from the state cannabis commission show that the average cost of an eighth of an ounce dropped to $14.20 last November, a steep decline compared with earlier years of the legal market.

According to commission figures, the state has roughly 1-to-1.2 square feet of approved growing canopy for every adult aged 21 and over. That level of production capacity exceeds what is available in nearby Connecticut, where retail prices remain higher.

Regulators have not yet decided whether to implement a freeze. Commissioners recently voted to schedule a future public hearing to examine the proposal. If approved, the moratorium would apply only to new cultivation applications. Permits that are already in progress would continue moving through the system.

Commissioner Kim Roy indicated that many operators are struggling and suggested that a pause could offer some breathing room. She said businesses across the supply chain, from growers to storefronts, are feeling the strain of tighter margins and intense competition.

The number of active cultivators has already declined. State records show 132 cannabis growers currently operating. At the same time, 158 cultivation licenses have lapsed, and 25 approved license holders have yet to launch operations.

Several multistate cannabis companies have also withdrawn from the state in recent years. In 2023, Trulieve closed its operations in the state while Ayr Wellness shuttered a 217,000-square-foot cultivation facility last summer, marking one of the more visible pullbacks in the market.

Massachusetts does not impose a statewide cap on the number of marijuana licenses. That open structure helped fuel rapid expansion after legalization, but has also contributed to today’s crowded landscape.

Other states have tried limiting new entrants, with mixed outcomes. In Oklahoma, a suspension on new medical marijuana licenses remains in place until August as Governor Kevin Stitt pushes for sweeping changes to the industry.

Meanwhile, Oregon adopted a “one in, one out” approach in 2024, allowing a new cultivation permit only when another operator exits or transfers a license. According to law firm Harris Sliwoski, 24 growers left the Oregon market last year.

Legal marijuana markets everywhere have their own fair share of oversaturation, and many companies like SNDL Inc. (NASDAQ: SNDL) are having to come up with innovative ways to not only survive but also thrive under the challenging conditions in the jurisdictions where they have operations.

About CNW420

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com